Scott Henry
Stock Analyst at Alliance Global Partners
(1.69)
# 3,319
Out of 4,964 analysts
52
Total ratings
41.51%
Success rate
-3.39%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.29 | +132.56% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.15 | +226.09% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $4.64 | +29.31% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $2.97 | +237.07% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.81 | +239.09% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.24 | +17.40% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.95 | +322.12% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.42 | +519.83% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.46 | +2,507.00% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.62 | +13.29% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.88 | +19.49% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $27.58 | -12.98% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $20.38 | -23.95% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $95.27 | -39.12% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $72.97 | -50.66% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.34 | +720.90% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.31 | +81.27% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.18 | +263,661.47% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.85 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $1.07 | +554.21% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $30.81 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.65 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.99 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.29
Upside: +132.56%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.15
Upside: +226.09%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $4.64
Upside: +29.31%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $2.97
Upside: +237.07%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.81
Upside: +239.09%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.24
Upside: +17.40%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.95
Upside: +322.12%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.42
Upside: +519.83%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.46
Upside: +2,507.00%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.62
Upside: +13.29%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $10.88
Upside: +19.49%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $27.58
Upside: -12.98%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $20.38
Upside: -23.95%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $95.27
Upside: -39.12%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $72.97
Upside: -50.66%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.34
Upside: +720.90%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.31
Upside: +81.27%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.18
Upside: +263,661.47%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.85
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $1.07
Upside: +554.21%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $30.81
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.65
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.99
Upside: -